NCT00413829View on ClinicalTrials.gov

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

March 31, 2008

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Intravitreal ranibizumab with photodynamic therapy

Intravitreal injection, photodynamic therapy

Trial Locations (1)

Unknown

Klinik und Poliklinik fuer Augenheilkunde, Inselspital, Bern

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT00413829 - Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) | Biotech Hunter | Biotech Hunter